Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lithium pyruvate is an experimental lithium salt compound combining lithium ions with pyruvate (pyruvic acid). It is being investigated as a potential mood stabilizer with enhanced cytoprotective and antioxidant properties. The compound combines the mood-stabilizing effects of lithium, which is the gold standard treatment for bipolar disorder, with the metabolic and antioxidant benefits of pyruvate, a key metabolite in aerobic glycolysis and the Krebs cycle. Research has demonstrated pronounced cytoprotective effects under oxidative stress conditions on human peripheral blood mononuclear cells, with the protective effect being independent of donor health status. The compound showed direct antioxidant effects and beneficial influence on intracellular energy processes. Lithium pyruvate enhances cellular defense against reactive oxygen species (ROS) and may provide neuroprotective benefits through multiple pathways including effects on bcl-2 protein and glycogen synthase kinase 3β. Studies suggest it could be developed as a psychotropic antioxidant with combined therapeutic advantages over standard lithium salts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lithium pyruvate.